Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03952468 · ClinicalTrials.gov registry record · NA
Combined TMS and Brief Cognitive Behavioral Therapy to Reduce Suicide
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03952468: Completed NA study, sponsored by VA Office of Research and Development.
NCT03952468 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03952468, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
High rates of Veteran suicide remain a tragedy. Rates of Veteran suicide have not decreased for 10 years, despite the best efforts of the field. Those interventions that do exist have only modest effects, which are simply insufficient for the magnitude of the problem. This proposal will combine two treatments - brief cognitive behavioral therapy (BCBT) and repetitive transcranial magnetic stimulation (TMS). Both of these interventions can reduce suicide and are available at Veterans Affairs Medical Centers across the country, yet to date no one has combined these therapies. This proposal will test the effect of this combination, and, if successful, will lead to a novel yet implementable new treatment to reduce Veteran suicide.
Interventions
- DEVICE Transcranial Magnetic Stimulation
- OTHER Brief Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03952468
The ClinicalTrials.gov registry entry for NCT03952468 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.
NCT03952468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03952468 about?
NCT03952468 is a clinical study titled "Combined TMS and Brief Cognitive Behavioral Therapy to Reduce Suicide". High rates of Veteran suicide remain a tragedy. Rates of Veteran suicide have not decreased for 10 years, despite the best efforts of the field. Those interventions that do exist have only modest effects, which are simply insufficient for the magnitude of the problem. This proposal will combine two ...
What is the current status of trial NCT03952468?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2019-11-04. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03952468?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Brief Cognitive Behavioral Therapy (OTHER).
Who is sponsoring clinical trial NCT03952468?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.